Clinical Pharmacokinetics and Potentially Important Drug Interactions of Sulphinpyrazone
- 1 January 1982
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 7 (1) , 42-56
- https://doi.org/10.2165/00003088-198207010-00003
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- The Effects of Two Different Dosage Regimens of Sulphinpyrazone on Platelet Function ex vivo and Blood Chemistry in ManPathophysiology of Haemostasis and Thrombosis, 1981
- The Effect of Sulphinpyrazone and Its Metabolites on Platelet Function in vitro and ex vivoPathophysiology of Haemostasis and Thrombosis, 1981
- SulfinpyrazoneDrugs, 1980
- Plasma Levels and Effects of Sulfinpyrazone in Patients Requiring Chronic HemodialysisThe Journal of Clinical Pharmacology, 1980
- Sulfinpyrazone in the Prevention of Sudden Death after Myocardial InfarctionNew England Journal of Medicine, 1980
- Protein binding of sulfonamides and displacing effects of sulfinpyrazone on the bound sulfonamides in nephrotic patients in the remissive stage.CHEMICAL & PHARMACEUTICAL BULLETIN, 1980
- Sulphinpyrazone and warfarin after myocardial infarction.BMJ, 1979
- Hazards of sulphinpyrazone.BMJ, 1978
- Possible Interaction of Sulfinpyrazone with CoumarinsNew England Journal of Medicine, 1978
- Value of Uricosuric Agents and in Particular of G.28 315 in GoutAnnals of the Rheumatic Diseases, 1958